RT Journal Article
SR Electronic
T1 Tracing DAY-ZERO and Forecasting the Fade out of the COVID-19 Outbreak in Lombardy, Italy: A Compartmental Modelling and Numerical Optimization Approach
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.17.20037689
DO 10.1101/2020.03.17.20037689
A1 Russo, Lucia
A1 Anastassopoulou, Cleo
A1 Tsakris, Athanasios
A1 Bifulco, Gennaro Nicola
A1 Campana, Emilio Fortunato
A1 Toraldo, Gerardo
A1 Siettos, Constantinos
YR 2020
UL http://medrxiv.org/content/early/2020/03/27/2020.03.17.20037689.abstract
AB Background Italy currently constitutes the epicenter of the novel coronavirus disease (COVID-19) pandemic, having surpassed China’s death toll. The disease is sweeping through Lombardy, which remains in lockdown since the 8th of March. As of the same day, the isolation measures taken in Lombardy have been extended to the entire country. On March 11, the WHO declared COVID-19 pandemic. Here, we provide estimates for: (a) the DAY-ZERO of the outbreak in Lombardy, Italy; (b) the actual number of exposed/infected cases in the total population; (c) the basic reproduction number (R0); (d) the “effective” per-day disease transmission and mortality rates; and, importantly, (e) a forecast for the fade out of the outbreak on the basis of the released data of confirmed cases for Lombardy from February 21 to March 8, the day of lockdown.Methods To deal with the uncertainty in the number of actual exposed/ infected cases in the total population, we address a new compartmental Susceptible/ Exposed/ Infectious/ Recovered/ Dead (SEIRD) model with two compartments of infectious persons: one modelling the total cases in the population and another modelling the confirmed cases. The parameters of the model corresponding to the recovery period, and the time from exposure to the time that an individual starts to be infectious, have been set as reported from clinical studies on COVID-19. For the estimation of the DAY-ZERO of the outbreak in Lombardy, as well as of the “effective” per-day transmission and mortality rates for which no clinical data are available, we have used the SEIRD simulator to fit the data from February 21 to the 8th of March, the lockdown day of Lombardy and of all Italy. This was accomplished by solving a mixed-integer optimization problem with the aid of genetic algorithms. Based on the computed values, we also provide an estimation of the basic reproduction number R0. Furthermore, based on an estimation for the reduction in the “effective” transmission rate of the disease as of March 8 that reflects the suspension of almost all activities in Italy, we ran the simulator to forecast the fade out of the epidemic. For this purpose, we considered the reduction in mobility in Lombardy from mobile phone data released on March 17, the effect of social distancing, and the draconian measures taken by the government on March 20 and March 21, 2020.Findings Based on the proposed methodological procedure, we estimated that the actual cumulative number of exposed cases in the total population in Lombardy on March 8 was of the order of 15 times the confirmed cumulative number of infected cases. According to this scenario, the DAY-ZERO for the outbreak in Lombardy was the 21st of January 2020. The “effective” per-day disease transmission rate for the period until March 8 was found to be 0.779 (90% CI: 0.777-0.781), while the “effective” per-day mortality rate was found to be 0.0174 (90% CI: 0.0154-0.0192). Based on these values, the basic reproduction rate R0 was found to be 4.04 (90% CI: 4.03-4.05).Importantly, simulations show that the fade out of the COVID-19 pandemic in Lombardy is expected to occur by the end of May - early June, 2020, if the draconian, as of March 20 and March 21, measures are maintained.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementNo funding was received for this study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are provided as supplementary information.